metformin a glp 1 New aspects of an old drug: as glucagon-like peptide (GLP-1) enhancer and sensitiser | Diabetologia Similar cellular effects of metformin,

GLP-1 drugs have been used by large shares of adults who say they have been diagnosed with diabetes (57% have ever used the drug, including 45% who are currently using), heart disease (40% ever, 29% currently), or as obese or overweight in the past five years (34% ever, 23% currently)

Despite being the first line of treatment, it cannot completely prevent pain attacks (Sever et al., 2014)

Li S, Peng J, Wang H, Zhang W, Brown JM, Zhou Y, Wu Q

2021 PAAS National LLC All Rights Reserved

For IBD specifically, KPV's evidence is more targeted and mechanism-specific than BPC-157's gut evidence

Both are bedtime injections